Fcã receptor iia (cd32) heterogeneity in patients with recurrent bacterial respiratory tract infections

Lieke A.M. Sanders*, Jan G.J. Van de Winkel, Ger T. Rijkers, Marleen M. Voorhorst-Ogink, Masja De Haas, Peter J.A. Capel, Ben J.M. Zegers

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

159 Citations (Scopus)

Abstract

Fc-ãRIIa (CD32) is the sole IgG Fc receptor capable ofinteraction with human IgG2, the main IgG subclass of bacterial capsular polysaccharides. The two genetically determined allotypes of human Fc-ãRIIa, Fc-ãRIIa-R131 and IIa-H 131 alleles, have functionally different reactivities with human IgG2. The capacity of polymorphonuclear leukocytes (PMNL) homozygous for Fc-ãRIIa-H/HI31 for IgG2 opsonized bacteria is significantly higher than phagocytosis by PMNL homozygous for Fc-ãRIIa-R/R131, independent of the Fc-ãRIIIb-NA1/NA2 (CDI6) allelic polymorphism. To test the clinical significance of these FcãR polymorphisms, Fc-ãRIIa and Fc-ãRIIIb phenotypes of 48 children with recurrent bacterial respiratory tract infections were determined. Fc-ãRIIa-H/HI31 was less than half that observed in 123 healthy adults (P = 01) IgG2 responses were low in 25 of 48 patients after immunization with pneumococcal vaccine. These results suggest that Fc-ãRIIa polymorphism may contribute to increased susceptibility to infections with encapsulated bacteria in a childhood population with low IgG2 anti-carbohydrate antibodies.

Original languageEnglish
Pages (from-to)854-861
Number of pages8
JournalJournal of Infectious Diseases
Volume170
Issue number4
DOIs
Publication statusPublished - Oct 1994

Fingerprint

Dive into the research topics of 'Fcã receptor iia (cd32) heterogeneity in patients with recurrent bacterial respiratory tract infections'. Together they form a unique fingerprint.

Cite this